The SPDR S&P Biotech ETF (XBI) reported a significant outflow of approximately $283.7 million, a decrease of 3.5% in shares outstanding, dropping from 67,750,000 to 65,400,000 in just one week. This data comes amid trading on [insert date].
Notable underlying components of XBI include Vaxcyte Inc (PCVX), which rose 1.8%; Mirum Pharmaceuticals Inc (MIRM), which climbed 0.5%; and Revolution Medicines Inc (RVMD), which increased by 1.2%. The current trading price of XBI is $123.33, with a 52-week low of $66.66 and a high of $132.09.
Weekly monitoring of ETF share changes is crucial as significant inflows or outflows can impact the ETF’s underlying holdings, further influencing individual stock prices.
